Detalhe da pesquisa
1.
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Clin Immunol
; 251: 109321, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019421
2.
The seasonality as a relevant aspect to be considered for differential diagnosis of Trypanosoma vivax infection and co-infections in female cattle.
Comp Immunol Microbiol Infect Dis
; 109: 102180, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653007
3.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Sci Rep
; 14(1): 7709, 2024 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565882
4.
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
NPJ Vaccines
; 9(1): 54, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459059
5.
Rhythmic profile of memory T and B-cells along childhood and adolescence.
Sci Rep
; 13(1): 20978, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017254
6.
Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study.
Front Immunol
; 14: 1176898, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37122732
7.
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
Vaccine
; 41(44): 6514-6528, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661534
8.
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.
Vaccine
; 40(32): 4580-4593, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728990
9.
Serum soluble mediator waves and networks along healthy ageing.
Exp Gerontol
; 164: 111771, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35351526
10.
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Vaccine
; 40(5): 798-810, 2022 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969545
11.
Serum Soluble Mediator Profiles and Networks During Acute Infection With Distinct DENV Serotypes.
Front Immunol
; 13: 892990, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711447
12.
Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy.
Antiviral Res
; 190: 105073, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887350
13.
Phenotypic and Functional Signatures of Peripheral Blood and Spleen Compartments of Cynomolgus Macaques Infected With T. cruzi: Associations With Cardiac Histopathological Characteristics.
Front Cell Infect Microbiol
; 11: 701930, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34336723
14.
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.
Sci Rep
; 11(1): 10431, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001945
15.
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.
Front Immunol
; 11: 1382, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32765496
16.
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis.
Arthritis Res Ther
; 21(1): 75, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871593
17.
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 2433, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31695694
18.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Front Immunol
; 10: 2192, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616412
19.
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 1211, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31293563
20.
Short-lived immunity after 17DD Yellow Fever single dose indicates that booster vaccination may be required to guarantee protective immunity in children
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-36054